Corcept Therapeutics CORT Lessee Operating Lease Liability Undiscounted Excess Amount
Lessee Operating Lease Liability Undiscounted Excess Amount at other companies
Other financials
Where this comes from
Reported directly by Corcept Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount.
The official record: Corcept Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Corcept Therapeutics's lessee operating lease liability undiscounted excess amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Corcept Therapeutics's lessee operating lease liability undiscounted excess amount?
- Corcept Therapeutics (CORT) reported lessee operating lease liability undiscounted excess amount of $1.84M in Q1 2026.
- How has Corcept Therapeutics's lessee operating lease liability undiscounted excess amount changed year-over-year?
- Corcept Therapeutics's lessee operating lease liability undiscounted excess amount increased by 11.8% year-over-year, from $1.65M to $1.84M.